Spinal Stimulation and Mobility Devices
Launched by UNIVERSITY OF WASHINGTON · Aug 25, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how combining non-invasive spinal stimulation with mobility devices can help improve movement in children with conditions like cerebral palsy, stroke, and other neurological challenges. The researchers want to see how these techniques work both separately and together to boost mobility in kids, aiming for a better understanding of how to support their movement abilities.
To join the study, participants need to be between the ages of 4 and 70 and have a stable neurological condition. They should be able to follow simple instructions and provide feedback about their experience during the visits. However, there are some important exclusions; for example, individuals with serious heart or lung problems, uncontrolled seizures, or certain implanted medical devices cannot participate. Those who choose to take part can expect to engage in sessions where they will use the stimulation and mobility devices while sharing their thoughts on how comfortable they feel throughout the process. This study is currently recruiting participants, and it offers a valuable opportunity to contribute to research that may help improve mobility for children with these conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • have a neurologic condition
- • are 4-70 years of age
- • have stable medical condition
- • can perform simple cued motor tasks and who can follow 2-3 step commands
- • who are volunteering to be involved in this study
- • can provide feedback on comfort and experience during lab visits
- Exclusion Criteria:
- • have significant medical disease; including uncontrolled systemic hypertension with values above 170/100 mmHg; cardiac or pulmonary disease; uncorrected coagulation abnormalities or need for therapeutic anticoagulation.
- • have cardiovascular or musculoskeletal disease or injury that would prevent full participation in physical therapy intervention
- • have a history of uncontrolled seizures
- • have unhealed fracture or other musculoskeletal impairment that might interfere with lower extremity rehabilitation or testing activities
- • are dependent on ventilation support
- • have implanted stimulator (e.g. epidural stimulator, vagus nerve stimulator, pacemaker, cochlear implant, etc) or drug delivery device (e.g. baclofen pump)
- • have history of orthopedic surgery in lower extremities or neurosurgery that may be a confounding factor for interpretation of the results (such as tendon transfer, tendon or muscle lengthening for spasticity management, injection therapies to lower extremity muscles, etc.) in last 12 months
- • have established osteoporosis and taking medication for osteoporosis treatment.
- • have rheumatic diseases (rheumatoid arthritis, systemic lupus erythematosus, etc.)
- • have active cancer
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Patients applied
Trial Officials
Katherine Steele, PHD
Principal Investigator
University of Washington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials